European Society of Cardiology Guidelines Recommend Bivalirudin -Angiox, Angiomax- Replace Heparins in PCI.

Business Wire › March 17, 2005

Linked as:

Extract

European Society of Cardiology Guidelines Recommend Bivalirudin -Angiox, Angiomax- Replace Heparins in PCI.

PARSIPPANY, N.J. -- The European Society of Cardiology, a leading independent cardiology body in Europe, this week published Guidelines for Percutaneous Coronary Interventions, recommending that the anticoagulant bivalirudin (tradename Angiox(TM) in Europe and Angiomax(R) in U.S.) replace heparins (unfractionated ...

See the full content of this document